Form 8-K - Current report:
SEC Accession No. 0001493152-18-003202
Filing Date
2018-03-12
Accepted
2018-03-12 07:30:30
Documents
29
Period of Report
2018-03-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 26948
2 ex99-1.htm EX-99.1 24767
3 ex99-2.htm EX-99.2 977
4 ex99-1_001.jpg GRAPHIC 46024
5 ex99-1_002.jpg GRAPHIC 121212
6 ex99-1_003.jpg GRAPHIC 52305
7 ex99-1_004.jpg GRAPHIC 48607
8 ex99-1_005.jpg GRAPHIC 71724
9 ex99-1_006.jpg GRAPHIC 45278
10 ex99-1_007.jpg GRAPHIC 59678
11 ex99-1_008.jpg GRAPHIC 76132
12 ex99-1_009.jpg GRAPHIC 81976
13 ex99-1_10.jpg GRAPHIC 69436
14 ex99-1_11.jpg GRAPHIC 75896
15 ex99-1_12.jpg GRAPHIC 47188
16 ex99-1_13.jpg GRAPHIC 67431
17 ex99-1_14.jpg GRAPHIC 82970
18 ex99-1_15.jpg GRAPHIC 80012
19 ex99-1_16.jpg GRAPHIC 15136
20 ex99-1_17.jpg GRAPHIC 87126
21 ex99-1_18.jpg GRAPHIC 64489
22 ex99-1_19.jpg GRAPHIC 20486
23 ex99-1_20.jpg GRAPHIC 127627
24 ex99-1_21.jpg GRAPHIC 72107
25 ex99-1_22.jpg GRAPHIC 84141
26 ex99-1_23.jpg GRAPHIC 91377
27 ex99-1_24.jpg GRAPHIC 62178
28 ex99-1_25.jpg GRAPHIC 75852
29 ex99-2_001.jpg GRAPHIC 152191
  Complete submission text file 0001493152-18-003202.txt   2643727
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 18682025
SIC: 2834 Pharmaceutical Preparations